Sudden cardiac death and the potential role of beta-adrenoceptor-blocking drugs
- PMID: 7907178
- PMCID: PMC2400014
- DOI: 10.1136/pgmj.69.818.903
Sudden cardiac death and the potential role of beta-adrenoceptor-blocking drugs
Abstract
Sudden cardiac death is a major health problem in the industrially developed countries. The risk of sudden cardiac death may be reduced by early detection of coronary heart disease, elimination of the risk factors, treatment of the ischaemia in patients known to have coronary heart disease and suppression of ventricular arrhythmias. Of all the therapeutic measures currently available to reduce the risk of sudden cardiac death, beta-adrenoceptor-blocking drugs (beta blockers) appear to be the most effective. In this paper their actions are reviewed and evidence for their efficacy is presented.
Similar articles
-
The role of beta-adrenergic blocking agents in preventing sudden cardiac death.Circulation. 1992 Jan;85(1 Suppl):I107-11. Circulation. 1992. PMID: 1345815 Review.
-
Beta-blockers for preventing sudden cardiac death.Postgrad Med. 2003 Dec;114(6 Suppl Role):30-4. doi: 10.3810/pgm.12.2003.suppl33.203. Postgrad Med. 2003. PMID: 19667667
-
Possible role of beta-blockers in the prevention of sudden cardiac death (SCD) in patients with coronary heart disease (CHD).Panminerva Med. 1994 Jun;36(2):71-5. Panminerva Med. 1994. PMID: 7831062 Review.
-
[Sudden cardiac death. Significance of beta blockaders].Tidsskr Nor Laegeforen. 1992 Sep 20;112(22):2843-7. Tidsskr Nor Laegeforen. 1992. PMID: 1357774 Review. Norwegian.
-
Beta-blockers and sudden cardiac death.Ann Intern Med. 1995 Sep 1;123(5):358-67. doi: 10.7326/0003-4819-123-5-199509010-00007. Ann Intern Med. 1995. PMID: 7625625 Review.
Cited by
-
Sudden cardiac death and the potential role of beta adrenoceptor-blocking drugs.Postgrad Med J. 1994 Jul;70(825):521-2. doi: 10.1136/pgmj.70.825.521. Postgrad Med J. 1994. PMID: 7937438 Free PMC article. No abstract available.
-
Sudden cardiac death in patients with hypertension. An association with diuretics and beta-blockers?Drug Saf. 1997 Apr;16(4):233-41. doi: 10.2165/00002018-199716040-00001. Drug Saf. 1997. PMID: 9113491 Review.
-
Metoprolol: a pharmacoeconomic and quality-of-life evaluation of its use in hypertension, post-myocardial infarction and dilated cardiomyopathy.Pharmacoeconomics. 1994 Oct;6(4):370-400. doi: 10.2165/00019053-199406040-00004. Pharmacoeconomics. 1994. PMID: 10147474 Review.